Clinical Evaluation of Bacitracin

Completed · Phase 2

Conditions studied: Allergic Contact Dermatitis

In brief

The purpose of this study is to establish a concentration of a bacitracin-patch for diagnosing allergic contact dermatitis.

Key facts

Study ID

NCT00132600

Run by

Mekos Laboratories AS

People needed

20

Starts

2005-04-01

Expected to finish

2005-07-01

Last updated by the study team

2005-10-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Positive bacitracin patch test within the latest 5 years.
• Age greater than or equal to 18 years.
• Signed informed consent.

You may not qualify if…

• Topical treatment with corticosteroids or immunosuppressives during the latest 7 days on the test area or near the test area.
• Systemic treatment with corticosteroids or immunosuppressives during the latest 7 days.
• Treatment with ultraviolet (UV)-light during the latest 3 weeks.
• Widespread active dermatitis or dermatitis on test area.
• Breast-feeding or pregnancy. Females of childbearing potential must demonstrate a negative pregnancy test before inclusion in the study.
• Subjects not able to cooperate.

Where it is running

• Dermatological Clinic (Joseph Fowler MD) — Louisville, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.